PRACTICAL ONCOLOGY JOURNAL ›› 2010, Vol. 24 ›› Issue (3): 255-259.doi: 10.3969/j.issn.1002-3070.2010.03.015

Previous Articles     Next Articles

Analysis on the short-term effect of concurrent radiochemotherapy plus adjuvant chemotherapy in advanced cervical cancer

WANG Shun, ZHANG Dashui, LIU Sha, WANG Mingkun, PAN Tao   

  1. Department of Radiation Oncology,The Affiliated Hospital of Hainan Medical College,HaiKou 570102
  • Received:2010-04-06 Online:2010-06-28 Published:2015-01-24

Abstract: Objective To observe the effect of concurrent chemoradiotherapy plus adjuvant chemotherapy in patients with advanced cervical squamous cell carcinoma.Method 156 cases with stage Ⅱa-Ⅲb cervical squamous cell carcinoma were randomly divided into both the concurrent chemoradiotherapy group(experimental group)and radiotherapy group(control group).Radiotherapy was administered by intracavity and external beam radiation therapy,dose of point A were given for 40Gy-48Gy/10f-12f and dose of point B for 46Gy-50Gy/23f-25f.In the same time,experimental group was treated by DDP 40 mg/d 1,3,5 intravenous drip,repeated every week.Tenth day after radiation therapy,adjuvant chemotherapy using TP program was given three times,21 days intervally.Results The short-term efficiency for the experimental group and the control group was 88.61% and 75.33% respectively (P<0.05).In one year to three year after treatment,the overall survival rate(OS)and distance metastasis free survival rate(DMF)and local recurrence free(LRF)for the experimental group were different significantly (P<0.05)than the control group.Quality of life of were significantly improved after treatment.Lack of appetite,diarrhea and blood toxicity of the treatment modalities were observed as limiting toxicity(P<0.05).Conclusion Concurrent chemoradiotherapy plus adjuvant chemotherapy for advanced cervical cancer patients can improve short-term and quality of life,the limiting toxicity can be tolerated.

CLC Number: